These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23567442)

  • 1. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
    Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
    Am J Geriatr Psychiatry; 2013 Nov; 21(11):1082-5. PubMed ID: 23567442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yokukansan treatment in chronic renal failure patients with dementia receiving hemodialysis: an open label study.
    Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
    Am J Geriatr Psychiatry; 2011 Oct; 19(10):906-7. PubMed ID: 21795962
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
    Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
    Nagata K; Yokoyama E; Yamazaki T; Takano D; Maeda T; Takahashi S; Terayama Y
    Phytomedicine; 2012 Apr; 19(6):524-8. PubMed ID: 22421528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms.
    Kimura T; Hayashida H; Furukawa H; Takamatsu J
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):207-10. PubMed ID: 20447015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
    Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: a pilot study.
    Azermai M; Petrovic M; Engelborghs S; Elseviers MM; Van der Mussele S; Debruyne H; Van Bortel L; Vander Stichele RH
    Aging Ment Health; 2013; 17(1):125-32. PubMed ID: 22928861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
    Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients.
    Ikarashi Y; Mizoguchi K
    Pharmacol Ther; 2016 Oct; 166():84-95. PubMed ID: 27373856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.
    Hatano T; Hattori N; Kawanabe T; Terayama Y; Suzuki N; Iwasaki Y; Fujioka T;
    J Neural Transm (Vienna); 2014; 121(3):275-81. PubMed ID: 24169925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of severe hypokalemia caused by a Chinese herbal remedy (Yokukansan) in an 81-year-old woman with dementia].
    Nishiyama N; Takeshita M; Tanaka K; Miyao M; Mizuno Y
    Nihon Ronen Igakkai Zasshi; 2011; 48(5):553-7. PubMed ID: 22323035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials.
    Matsuda Y; Kishi T; Shibayama H; Iwata N
    Hum Psychopharmacol; 2013 Jan; 28(1):80-6. PubMed ID: 23359469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.